Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hologic (HOLX)
NASDAQ:HOLX
Hologic (HOLX) Stock Price & Analysis
915 Followers
HOLX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$64.02 - $82.45
Previous Close$75.02
Volume125.92K
Average Volume (3M)1.59M
Market Cap
$17.39B
Enterprise Value$18.15B
Total Cash (Recent Filing)$1.93B
Total Debt (Recent Filing)$2.58B
Price to Earnings (P/E)38.6
Beta0.58
Next Earnings
Jul 24, 2024EPS Estimate
$1.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.94
Shares Outstanding233,376,948
10 Day Avg. Volume1,414,856
30 Day Avg. Volume1,586,243
Standard Deviation0.09
R-Squared0.32
Alpha0.00189
Financial Highlights & Ratios
Price to Book (P/B)33.98
Price to Sales (P/S)4.34
Price to Cash Flow (P/CF)19.90
P/FCF Ratio19.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.55
Enterprise Value/Gross Profit6.38
Enterprise Value/Ebitda25.61
Forecast
1Y Price Target
$89.00Price Target Upside19.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
Hologic News
Bulls Say, Bears Say
Bulls Say
Company ResilienceThe company has emerged stronger from COVID, with a diversified position across various health sectors, demonstrating resilience and adaptability.
Financial PerformanceRevenue exceeded consensus estimates, signaling the company's ability to surpass market expectations and maintain its growth momentum.
Product Demand And InnovationThe acquisition of Endomag brings innovative, non-radioactive imaging guidance systems to the company's portfolio, likely enhancing its breast health offerings and market presence.
Bears Say
ProfitabilityGross margins were slightly below consensus, which could indicate cost pressures or other challenges affecting profitability.
Revenue ForecastGuidance for future revenue came in below consensus estimates due to foreign exchange headwinds.
Sector PerformanceBreast Health showed slower growth which may offset other positive performance areas.
---
Ownership Overview
14.53% Insiders
32.67% Mutual Funds
50.67% Other Institutional Investors
2.14% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
HOLX FAQ
What was Hologic’s price range in the past 12 months?
Hologic lowest stock price was $64.02 and its highest was $82.45 in the past 12 months.
What is Hologic’s market cap?
Currently, no data Available
When is Hologic’s upcoming earnings report date?
Hologic’s upcoming earnings report date is Jul 24, 2024 which is in 65 days.
How were Hologic’s earnings last quarter?
Hologic released its earnings results on May 02, 2024. The company reported $1.03 earnings per share for the quarter, beating the consensus estimate of $0.978 by $0.052.
Is Hologic overvalued?
According to Wall Street analysts Hologic’s price is currently Undervalued.
Does Hologic pay dividends?
Hologic does not currently pay dividends.
What is Hologic’s EPS estimate?
Hologic’s EPS estimate is $1.02.
How many shares outstanding does Hologic have?
Hologic has 233,376,950 shares outstanding.
What happened to Hologic’s price movement after its last earnings report?
Hologic reported an EPS of $1.03 in its last earnings report, beating expectations of $0.978. Following the earnings report the stock price went up 0.83%.
Which hedge fund is a major shareholder of Hologic?
Among the largest hedge funds holding Hologic’s share is Bridgewater Associates, LP. It holds Hologic’s shares valued at 24M.
---
Hologic Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$89.00 (19.46% Upside)
$89.00 (19.46% Upside)
Blogger Sentiment
Bullish
HOLX Sentiment 75%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 227.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $690.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days >0.1%
Last 30 Days ▲ 1.5%
Last 30 Days ▲ 1.5%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-7.41%
12-Months-Change
Fundamentals
Return on Equity
9.20%
Trailing 12-Months
Asset Growth
-7.77%
Trailing 12-Months
Company Description
Hologic
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following business segments: Breast Health, Diagnostics, Medical Aesthetics, GYN Surgical, and Skeletal Health. The Breast Health segment includes a broad portfolio of breast imaging and related products and accessories, including digital mammography systems, computer-aided detection, for mammography and minimally invasive breast biopsy devices, breast biopsy site markers, and breast biopsy guidance systems. The Diagnostics segment comprises Aptima family of Assays, target capture/nucleic acid extraction techonolgy, transcription-mediated amplification technology, hybridization protection assay and dual kinetic assat technologies, instrumentation, and Invader Chemistry Platform. The Medical Aesthetics segment offers SculpSure; PicoSure, MedLite, and RevLite; and MonaLisa Touch. The GYN Surgical segment encompasses the NovaSure Endometrial Ablation System and the MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment covers the discovery and horizon X-ray bone densitometry system, an ultrasound-based osteoporosis assessment product, and Fluoroscan mini C-arm imaging products. The company was founded by S. David Ellenbogen and Jay A. Stein in 1986 and is headquartered in Marlborough, MA.
---
HOLX Company Deck
---
HOLX Earnings Call
Q2 2024
0:00 / 0:00
---
HOLX Revenue Breakdown
46.65% Diagnostics
35.55% Breast Health
14.99% GYN Surgical
2.81% Skeletal Health
---
HOLX Stock 12 Month Forecast
Average Price Target
$89.00
▲(19.46% Upside)
Technical Analysis
Best Analysts Covering HOLX
1 Year
1 Year Success Rate
10/16 ratings generated profit
1 Year Average Return
+3.16%
reiterated a buy rating 18 days ago
Copying Puneet Souda's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +3.16% per trade.
---